SALT LAKE CITY--(BUSINESS WIRE)--Paradigm Medical Industries, Inc. (OTCBB: PDMI.OB) has launched several internal programs aimed at expanding its position in the U.S. and global diagnostic ultrasound and early glaucoma detection markets. The Company’s initial efforts are aimed directly at the $25-million opportunity for its P60 Ultrasound BioMicroscope (UBM) and the growing glaucoma detection markets.
